Well-differentiated NSCLC considered as a whole were more commonly (five out of eight cases) fascin-negative, whereas poorly differentiated tumours more often (46 out of 57 cases) exhibited diffuse fascin immunoreactivity in more than 60% neoplastic cells (P=0.017). This evidence concerns the gene FSCN1 and non-small cell lung carcinoma.